Atypical cancer pattern in patients with Parkinson's disease
2005

Cancer Patterns in Parkinson's Disease Patients

Sample size: 14088 publication Evidence: moderate

Author Information

Author(s): Olsen J H, Friis S, Frederiksen K, McLaughlin J K, Mellemkjaer L, Møller H

Primary Institution: Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark

Hypothesis

Do constituents of tobacco smoke inhibit or delay the development of Parkinson's disease?

Conclusion

Patients with Parkinson's disease have a lower overall cancer incidence but higher risks for certain cancers like malignant melanoma and breast cancer.

Supporting Evidence

  • Overall cancer incidence was significantly lower in Parkinson's disease patients with a standardized incidence ratio (SIR) of 0.88.
  • Significantly reduced risks were found for smoking-related cancers, such as lung cancer (SIR, 0.38).
  • Increased risks were observed for malignant melanoma (SIR, 1.95) and nonmelanocytic skin cancer (SIR, 1.25).
  • The study included a large cohort of over 14,000 patients, providing robust data.
  • Men showed a significantly reduced risk for all cancers (SIR, 0.79), while women did not show a significant reduction (SIR, 0.98).
  • Patients were followed for an average of 5 years, with some followed for over 10 years.

Takeaway

People with Parkinson's disease get less cancer overall, but they are more likely to get skin and breast cancer.

Methodology

The study analyzed cancer incidence in a cohort of 14,088 patients with Parkinson's disease using data from the Danish National Hospital Register and the Danish Cancer Registry.

Potential Biases

Potential misclassification of cancer diagnoses and under-diagnosis due to communication difficulties in severely affected patients.

Limitations

The study may not fully represent all patients with Parkinson's disease, as those with less severe disease might be missing.

Participant Demographics

The cohort included 14,088 patients with a primary diagnosis of Parkinson's disease, average age at diagnosis was 72.8 years.

Statistical Information

Confidence Interval

0.8–0.9

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602279

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication